Globus Medical Inc (GMED)
81.10
0.00 (0.00%)
USD |
NYSE |
Nov 15, 16:00
81.18
+0.08
(+0.10%)
Pre-Market: 20:00
Globus Medical Price: 81.10 for Nov. 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 81.06 | 81.76 | 80.59 | 81.10 | 981501.0 |
| Nov 14, 2024 | 82.06 | 82.79 | 80.87 | 81.10 | 709353.0 |
| Nov 13, 2024 | 83.23 | 83.74 | 82.18 | 82.54 | 955300.0 |
| Nov 12, 2024 | 81.90 | 83.51 | 81.63 | 83.42 | 1.444M |
| Nov 11, 2024 | 82.18 | 82.58 | 81.41 | 81.99 | 1.634M |
| Nov 08, 2024 | 81.00 | 81.90 | 79.94 | 80.88 | 1.804M |
| Nov 07, 2024 | 81.95 | 82.93 | 81.46 | 81.97 | 1.414M |
| Nov 06, 2024 | 81.51 | 84.87 | 79.69 | 82.71 | 3.866M |
| Nov 05, 2024 | 74.34 | 76.13 | 74.23 | 75.58 | 1.275M |
| Nov 04, 2024 | 74.77 | 75.81 | 74.21 | 74.72 | 713179.0 |
| Nov 01, 2024 | 73.61 | 75.52 | 73.31 | 74.88 | 686225.0 |
| Oct 31, 2024 | 74.41 | 74.72 | 73.46 | 73.54 | 602015.0 |
| Oct 30, 2024 | 74.40 | 75.91 | 74.22 | 75.07 | 860414.0 |
| Oct 29, 2024 | 74.09 | 74.36 | 73.42 | 74.29 | 534198.0 |
| Oct 28, 2024 | 73.53 | 74.33 | 73.53 | 74.20 | 547278.0 |
| Oct 25, 2024 | 73.62 | 73.96 | 73.10 | 73.17 | 420464.0 |
| Oct 24, 2024 | 73.88 | 74.46 | 73.46 | 73.64 | 416184.0 |
| Oct 23, 2024 | 73.19 | 73.95 | 72.81 | 73.89 | 616160.0 |
| Oct 22, 2024 | 73.14 | 73.54 | 72.19 | 73.33 | 470913.0 |
| Oct 21, 2024 | 72.85 | 74.00 | 72.72 | 73.49 | 606212.0 |
| Oct 18, 2024 | 74.15 | 74.15 | 71.93 | 72.85 | 1.112M |
| Oct 17, 2024 | 74.50 | 74.86 | 73.33 | 73.92 | 970470.0 |
| Oct 16, 2024 | 74.37 | 75.98 | 74.12 | 74.88 | 1.480M |
| Oct 15, 2024 | 71.44 | 74.12 | 71.04 | 74.05 | 1.756M |
| Oct 14, 2024 | 70.94 | 71.24 | 70.30 | 71.19 | 403919.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
35.06
Minimum
Mar 16 2020
84.06
Maximum
Sep 08 2021
61.74
Average
60.46
Median
Mar 04 2021
Price Benchmarks
| Boston Scientific Corp | 86.99 |
| ResMed Inc | 234.74 |
| Haemonetics Corp | 89.22 |
| Abbott Laboratories | 115.90 |
| Stryker Corp | 390.08 |
Price Related Metrics
| PE Ratio | 121.04 |
| PS Ratio | 4.486 |
| Price to Book Value | 2.714 |
| Price to Free Cash Flow | 37.85 |
| Earnings Yield | 0.83% |
| Market Cap | 11.04B |
| Operating PE Ratio | 65.96 |
| Normalized PE Ratio | 90.98 |